Skip to main navigation Skip to search Skip to main content

Genetic cardiomyopathy and significant systolic heart failure treated with cardiac contractility modulation therapy

  • Aaron B. Hesselson
  • , Gaurang Vaidya
  • , Andrew Kolodziej

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)592-596
Number of pages5
JournalHeart Rhythm O2
Volume5
Issue number8
DOIs
StatePublished - Aug 2024

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Aaron B. Hesselson has served as a consultant for Impulse Dynamics. All authors attest they meet the current ICMJE criteria for authorship. Participants were in compliance with human studies committees and animal welfare regulations of the University of Kentucky and Food and Drug Association guidelines, including patient consent where appropriate.

Funders
University of Kentucky and Food and Drug Association

    Keywords

    • CSRP3
    • Cardiac contractility modulation
    • Genetic cardiomyopathy
    • LAMA4
    • LMNA
    • TNNT2
    • TTN

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Fingerprint

    Dive into the research topics of 'Genetic cardiomyopathy and significant systolic heart failure treated with cardiac contractility modulation therapy'. Together they form a unique fingerprint.

    Cite this